insights_auto
Bakit tumaas ang ONCY 3.53%?
Tingnan ang Higit pang Detalyechevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
$0.49
arrow_upward
+3.53%(+0.017) 1D
$0.50
arrow_upward
+1.73% (+0.0085)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 13, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ONCY...
Buksan
$0.49
Mataas
$0.50
Mababa
$0.45
Mkt. cap
64.70M
Avg. na dami
1.16M
Dami
4.20M
Mataas nang 52-wk
$1.32
Mababa nang 52-wk
$0.44
Beta
1.15
Mga natitirang share
127.51M
Bilang ng mga empleyado
29
Buksan
$0.49
Mataas
$0.50
Mababa
$0.45
Mkt. cap
64.70M
Avg. na dami
1.16M
Dami
4.20M
Mataas nang 52-wk
$1.32
Mababa nang 52-wk
$0.44
Beta
1.15
Mga natitirang share
127.51M
Bilang ng mga empleyado
29
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Yahoo! Finance Canada
·
6 oras ang nakalipas
Stocks in play: Oncolytics Biotech Inc
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Tungkol sa Oncolytics Biotech Inc
CEO-
Mga Empleyado29
Itinatag1998
HeadquartersCalgary, Alberta, Canada
Sektor-
Websiteoncolyticsbiotech.com